Clinical Trial Update: Safety and Efficacy of Sugammadex (Org 25969, MK-8616) in Participants With or Having a Past History of Pulmonary Disease (19.4.308) (P05932) (MK-8616-017) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of sugammadex in participants with or history of pulmonary disease; study completed and results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• General Anesthesia

Drugs mentioned

• Sugammadex (sugammadex)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Anesthesia, General | Phase 3 | Status: COMPLETED | Results posted: 2019-04-12